Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

681 ARTÍCULOS , VIENDO DEL 511 AL 525

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study

Bullich S, Mueller A, De Santi S, Koglin N, Krause S, Kaplow J, Kanekiyo M, Roé-Vellvé N, Perrotin A, Jovalekic A, Scott D, Gee M, Stephens A, Irizarry M.

Alzheimers Res Ther. 2022 Jul 27;14(1):105. doi: 10.1186/s13195-022-01048-x.

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, Salloway S, Sperling R, Zetterberg H, Teunissen CE.

Alzheimers Dement. 2022 Dec;18(12):2669-2686. doi: 10.1002/alz.12756. Epub 2022 Jul 31.

Artificial intelligence in dementia

Richardson A, Robbins CB, Wisely CE, Henao R, Grewal DS, Fekrat S.

Curr Opin Ophthalmol. 2022 Sep 1;33(5):425-431. doi: 10.1097/ICU.0000000000000881.

The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All

Rosen AC, Arias JJ, Ashford JW, Blacker D, Chhatwal JP, Chin NA, Clark L, Denny SS, Goldman JS, Gleason CE, Grill JD, Heidebrink JL, Henderson VW, Lavacot JA, Lingler JH, Menon M, Nosheny RL, Oliveira FF, Parker MW, Rahman-Filipiak A, Revoori A, Rumbaugh MC, Sanchez DL, Schindler SE, Schwarz CG, Toy L, Tyrone J, Walter S, Wang LS, Wijsman EM, Zallen DT, Aggarwal NT; members of AGREEDementia.

J Alzheimers Dis. 2022;90(3):953-962. doi: 10.3233/JAD-220458.

Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria

Dulewicz M, Kulczyńska-Przybik A, Mroczko P, Kornhuber J, Lewczuk P, Mroczko B.

Int J Mol Sci. 2022 Aug 2;23(15):8598. doi: 10.3390/ijms23158598.

A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study

Verde F, Aiello EN, Milone I, Giacopuzzi Grigoli E, Dubini A, Ratti A, Poletti B, Ticozzi N, Silani V.

Neurol Sci. 2022 Nov;43(11):6547-6550. doi: 10.1007/s10072-022-06346-8. Epub 2022 Aug 16.

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy

Oberstein TJ, Schmidt MA, Florvaag A, Haas AL, Siegmann EM, Olm P, Utz J, Spitzer P, Doerfler A, Lewczuk P, Kornhuber J, Maler JM.

Brain. 2022 Nov 21;145(11):4032-4041. doi: 10.1093/brain/awac297.

Are we ready to use anti-amyloid therapy in Alzheimer's disease?

Brucki SMD, César-Freitas KG, Spera RR, Borges CR, Smid J.

Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):15-23. doi: 10.1590/0004-282X-ANP-2022-S117.

Progression of Subjective Cognitive Decline to MCI or Dementia in Relation to Biomarkers for Alzheimer Disease: A Meta-analysis

Rostamzadeh A, Bohr L, Wagner M, Baethge C, Jessen F.

Neurology. 2022 Oct 25;99(17):e1866-e1874. doi: 10.1212/WNL.0000000000201072. Epub 2022 Aug 26.

Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review

Sagües-Sesé E, Rioja J, Garzón-Maldonado FJ, Narváez M, García-Arnés JA, García-Casares N.

J Alzheimers Dis. 2022;90(1):1-13. doi: 10.3233/JAD-220688.

Alzheimer's Disease Diagnosis Based on the Amyloid, Tau, and Neurodegeneration Scheme (ATN) in a Real-Life Multicenter Cohort of General Neurological Centers

Baldeiras I, Silva-Spínola A, Lima M, Leitão MJ, Durães J, Vieira D, Tábuas-Pereira M, Cruz VT, Rocha R, Alves L, Machado Á, Milheiro M, Santiago B, Santana I.

J Alzheimers Dis. 2022;90(1):419-432. doi: 10.3233/JAD-220587.

Demand Coupling Drives Neurodegeneration: A Model of Age-Related Cognitive Decline and Dementia

Turknett J, Wood TR.

Cells. 2022 Sep 7;11(18):2789. doi: 10.3390/cells11182789.

Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers

Kim SE, Kim HJ, Jang H, Weiner MW, DeCarli C, Na DL, Seo SW.

Int J Mol Sci. 2022 Sep 10;23(18):10490. doi: 10.3390/ijms231810490.

Willis Lecture: Biomarkers for Inflammatory White Matter Injury in Binswanger Disease Provide Pathways to Precision Medicine

Rosenberg GA.

Stroke. 2022 Nov;53(11):3514-3523. doi: 10.1161/STROKEAHA.122.039211. Epub 2022 Sep 23.

Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil

Alvarez XA, Winston CN, Barlow JW, Sarsoza FM, Alvarez I, Aleixandre M, Linares C, García-Fantini M, Kastberger B, Winter S, Rissman RA.

J Alzheimers Dis. 2022;90(2):705-717. doi: 10.3233/JAD-220575.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias